Paul Tudor Jones’s Enfusion, Inc. ENFN Stock Holding History

Paul Tudor Jones’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25,256	Closed	-$244K	–	3044
2022 Q4	$244K	Buy	+25,256	New	+$284K	﹤0.01%	2032
2022 Q3	–	Sell	-24,969	Closed	-$255K	–	2789
2022 Q2	$255K	Buy	24,969 +877	+4%	+$9.69K	0.01%	1673
2022 Q1	$306K	Buy	24,092 +1,300	+6%	+$19.9K	0.01%	1543
2021 Q4	$477K	Buy	+22,792	New	+$461K	0.01%	1509

Other funds holding ENFN

FMC

FTV Management Company San Francisco, California $514M AUM 4.45% 1-Year Est. Return

Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $2.83B AUM 12.55% 1-Year Est. Return

ACM

Ararat Capital Management Westport, Connecticut $213M AUM 42.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Paul Tudor Jones's ENFN Position: Q1 2023 in Review

Paul Tudor Jones sold out of Enfusion, Inc. (ENFN) in Q1 2023, closing a stake of 25,256 shares — an estimated $244K sold.

Paul Tudor Jones first reported a position in ENFN in Q4 2021 and held it in 4 quarters. The position peaked at $477K in Q4 2021. 90 funds tracked by Wall St. Rank hold ENFN as of Q1 2023.

Paul Tudor Jones reported no remaining Enfusion, Inc. position as of Q1 2023 after selling out during the quarter.
Paul Tudor Jones sold 25,256 Enfusion, Inc. shares in Q1 2023, an estimated $244K.
Paul Tudor Jones first reported a position in Enfusion, Inc. in Q4 2021 and held it in 4 quarters.
Paul Tudor Jones's Enfusion, Inc. position peaked at $477K in Q4 2021.
90 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2023.

Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.